register

Medical and Science

TGA seeks industry input in advance of increasing fees and charges

Health Industry Hub | February 17, 2020 |

Medical News: The TGA is undertaking a consultation through its website to seek stakeholder’s views and comments on TGA’s proposed fees and charges for 2020-21. The consultation paper outlines the proposed changes to fees and charges effective from 1 July 2020.

Consistent with its approach to consultation in relation to fees and charges, the TGA met with industry representative groups, including Medicines Australia, MTAA and AusBiotech, in a series of bilateral meetings between 12 December 2019 and 17 December 2019 to discuss the TGA’s financial outlook for 2020-21 and the proposed changes to fees and charges for 2020-21.

Prior to implementing the changes, the TGA would like to provide opportunity for any further comments through this consultation.

The document was released for consultation on Monday, 20 January 2020. Interested parties should respond by close of business Friday, 28 February 2020.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

The TGA preferred option is to increase all fees and charges by indexation factor. Under this option, all fees and charges would increase by 1.95% from 1 July 2020. The indexation increase is not only consistent with the long established practice but also provides opportunities for efficiency gains through business process improvements. In applying the indexation factor, fees and charges would be rounded to the nearest $10 for items less than $10,000 and to the nearest $100 for items $10,000 and above.

Submissions may provide any comments related to proposed fees and charges for 2020-21 only.

Members of peak industry bodies that the TGA held bilateral meetings with (listed in the consultation paper) are encouraged to present their comments through the respective peak body so that the industry body can present a consolidated industry feedback to the TGA.

Enhance corporate branding and boost thought leadership in the industry to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions developed by industry for industry.


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech CEOs set agenda for the new year

Medicines Australia and AusBiotech CEOs set agenda for the new year

Health Industry Hub | January 16, 2025 |

Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]

More


News & Trends - MedTech & Diagnostics

MTAA and PTA CEOs voice outlook for the year ahead

MTAA and PTA CEOs voice outlook for the year ahead

Health Industry Hub | January 16, 2025 |

Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]

More


ESG

Boehringer Ingelheim sets sustainability benchmark in NZ

Boehringer Ingelheim sets sustainability benchmark in NZ

Health Industry Hub | January 16, 2025 |

Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the […]

More


News & Trends - Pharmaceuticals

Scathing report exposes Labor’s mismanagement of the PBS

Scathing report exposes Labor’s mismanagement of the PBS

Health Industry Hub | January 16, 2025 |

The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]

More


This content is copyright protected. Please subscribe to gain access.